Brought to you by 
Gen-Probe and Univ. of MI test for prostate cancer markers
28 Apr 2021
Executive Summary
Gen-Probe (nucleic acid testing for diagnostics) licensed exclusive worldwide rights from the University of Michigan to develop diagnostics for markers recently associated with prostate cancer.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com